Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.

de Gramont, A

Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease. [electronic resource] - Cancer Jan 1987 - 301-4 p. digital

Publication Type: Journal Article

0008-543X

10.1002/1097-0142(19870115)59:2<301::aid-cncr2820590222>3.0.co;2-w doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Erythrocyte Indices
Hodgkin Disease--blood
Humans
Leukemia, Lymphoid--etiology
Mathematics
Mechlorethamine--therapeutic use
Prednisone--therapeutic use
Procarbazine--therapeutic use
Prognosis
Risk
Time Factors
Vincristine--therapeutic use